Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 2

first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  myocarditis
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

A concurrent presentation of nonspecific colitis as well as likely myocarditis

100%
Heavener T., Jepson M., Bushe B., Thotakura S., Chiles C.
Progress in Health Sciences
|
2018
|
vol. 8(1)
225-230
EN
An ST-segment elevation myocardial infarction represents a time-sensitive cardiac pathology with utmost importance placed upon timely coronary angiography with percutaneous coronary intervention. While emphasis is placed on atherosclerotic or thrombotic coronary occlusion, it is important to recognize other etiologies which may present in a similar fashion. This case demonstrates a 71-year-old female patient with prior coronary artery disease and stenting who presented with acute abdominal pain and elevated cardiac biomarkers as well as ST-segment elevation on initial EKG. Coronary angiography revealed only mild to moderate coronary lesions and patent stents while echocardiography was essential unchanged from prior evaluation. Computed tomography of the abdomen would show findings suggestive of infectious colitis and empiric antibiotics led to full resolution of symptoms. While no definitive cause for her cardiac manifestations was discovered, the authors propose coronary vasospasm or myo-pericarditis as likely etiologies in response to an overwhelming inflammatory state. The case underscores the importance of formulating a comprehensive differential diagnosis during the initial workup of a ST-segment elevation myocardial infarction.
2
Publication available in full text mode
Content available

COVID-19: szczepienie mRNA dorosłych i dzieci. Niskie ryzyko zapalenia mięśnia sercowego

63%
Krzystyniak K.
Gabinet Prywatny
|
2022
|
vol. 29 (280)
|
issue 01
5-8
EN
It is now estimated, that without vaccination, it is likely that almost everyone-including young children – will be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at some point in their lives. Vaccination with messenger RNA (mRNA) anti-COVID-19 vaccine is recommended for adults and for children between 5 and 11 years of age. Many parents are reluctant or opposed to seeking this protection for children. Low risk of myocarditis has been reported, approximately 5 cases per 1,000,000 individuals receiving mRNA COVID-19 vaccines, possibly as high as 1 per 10,000 in young men. However, a choice not to get a vaccine is not a risk-free choice; rather, it’s a choice to take a different and more serious risk.
PL
Aktualnie ocenia się, że bez szczepień prawdopodobnie prawie wszyscy - w tym małe dzieci - w pewnym momencie ich życia zostaną zarażeni koronawirusem SARS-CoV-2. Zaleca się szczepienie przeciw zakażeniom COVID-19 szczepionkami z informacyjnym mRNA dla dorosłych i dla dzieci w wieku 5–11 lat. Wielu rodziców jest niechętnych lub sprzeciwia się zapewnieniu dzieciom tej ochrony. Istnieje niskie ryzyko zapalenia mięśnia sercowego, około 5 przypadków na milion osób otrzymujących szczepionki mRNA anty-COVID-19. Jednak podjęcie negatywnej decyzji o zaszczepieniu nie jest wyborem pozbawionym ryzyka, a raczej jest to wybór poważniejszego ryzyka.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.